- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Pompe disease
- Meeting Date: November 2021
- Public Summary Document (PSD) November 2021 PBAC Meeting - (PDF 1780KB)
- Public Summary Document (PSD) November 2021 PBAC Meeting - (Word 1094KB)
Avalglucosidase alfa – November 2021
Avalglucosidase alfa: Powder for injection 100 mg in 10 mL; Nexviazyme®
Last updated
18 March 2022